289 related articles for article (PubMed ID: 27580180)
1. Risk analysis of the preanalytical process based on quality indicators data.
Flegar-Meštrić Z; Perkov S; Radeljak A; Kardum Paro MM; Prkačin I; Devčić-Jeras A
Clin Chem Lab Med; 2017 Mar; 55(3):368-377. PubMed ID: 27580180
[TBL] [Abstract][Full Text] [Related]
2. Application of failure mode and effects analysis in a clinical chemistry laboratory.
Jiang Y; Jiang H; Ding S; Liu Q
Clin Chim Acta; 2015 Aug; 448():80-5. PubMed ID: 26116892
[TBL] [Abstract][Full Text] [Related]
3. Reducing preanalytical laboratory sample errors through educational and technological interventions.
Lillo R; Salinas M; Lopez-Garrigos M; Naranjo-Santana Y; Gutiérrez M; Marín MD; Miralles M; Uris J
Clin Lab; 2012; 58(9-10):911-7. PubMed ID: 23163106
[TBL] [Abstract][Full Text] [Related]
4. Continual improvement of the pre-analytical process in a public health laboratory with quality indicators-based risk management.
Karadağ C; Demirel NN
Clin Chem Lab Med; 2019 Sep; 57(10):1530-1538. PubMed ID: 31050651
[TBL] [Abstract][Full Text] [Related]
5. Three years of preanalytical errors: quality specifications and improvement through implementation of statistical process control.
Salinas M; Lopez-Garrigos M; Flores E; Gutiérrez M; Lugo J; Uris J
Scand J Clin Lab Invest; 2009; 69(8):822-6. PubMed ID: 19929268
[TBL] [Abstract][Full Text] [Related]
6. Use of quality indicators to compare point-of-care testing errors in a neonatal unit and errors in a STAT central laboratory.
Cantero M; Redondo M; Martín E; Callejón G; Hortas ML
Clin Chem Lab Med; 2015 Feb; 53(2):239-47. PubMed ID: 25153415
[TBL] [Abstract][Full Text] [Related]
7. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory Errors and Patient Safety" project.
Sciacovelli L; Lippi G; Sumarac Z; West J; Garcia Del Pino Castro I; Furtado Vieira K; Ivanov A; Plebani M;
Clin Chem Lab Med; 2017 Mar; 55(3):348-357. PubMed ID: 27988505
[TBL] [Abstract][Full Text] [Related]
8. Failure mode and effect analysis in blood transfusion: a proactive tool to reduce risks.
Lu Y; Teng F; Zhou J; Wen A; Bi Y
Transfusion; 2013 Dec; 53(12):3080-7. PubMed ID: 23560475
[TBL] [Abstract][Full Text] [Related]
9. Quality indicators in the preanalytical phase of testing in a stat laboratory.
Grecu DS; Vlad DC; Dumitrascu V
Lab Med; 2014; 45(1):74-81. PubMed ID: 24719991
[TBL] [Abstract][Full Text] [Related]
10. Use of failure mode effect analysis (FMEA) to improve medication management process.
Jain K
Int J Health Care Qual Assur; 2017 Mar; 30(2):175-186. PubMed ID: 28256927
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of the total testing process based on quality indicators with the Sigma metrics.
Xia Y; Wang X; Yan C; Wu J; Xue H; Li M; Lin Y; Li J; Ji L
Clin Chem Lab Med; 2020 Jul; 58(8):1223-1231. PubMed ID: 32146438
[TBL] [Abstract][Full Text] [Related]
12. Quality Indicators for the Total Testing Process.
Plebani M; Sciacovelli L; Aita A
Clin Lab Med; 2017 Mar; 37(1):187-205. PubMed ID: 28153366
[TBL] [Abstract][Full Text] [Related]
13. Preanalytical errors in medical laboratories: a review of the available methodologies of data collection and analysis.
West J; Atherton J; Costelloe SJ; Pourmahram G; Stretton A; Cornes M
Ann Clin Biochem; 2017 Jan; 54(1):14-19. PubMed ID: 27614351
[TBL] [Abstract][Full Text] [Related]
14. Application of Failure Mode Effect Analysis to Improve the Care of Septic Patients Admitted Through the Emergency Department.
Alamry A; Al Owais SM; Marini AM; Al-Dorzi H; Alsolamy S; Arabi Y
J Patient Saf; 2017 Jun; 13(2):76-81. PubMed ID: 25119786
[TBL] [Abstract][Full Text] [Related]
15. Changes in error rates in the Australian key incident monitoring and management system program.
Gay S; Badrick T
Biochem Med (Zagreb); 2020 Jun; 30(2):020704. PubMed ID: 32292282
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unit.
Bonfant G; Belfanti P; Paternoster G; Gabrielli D; Gaiter AM; Manes M; Molino A; Pellu V; Ponzetti C; Farina M; Nebiolo PE
J Nephrol; 2010; 23(1):111-8. PubMed ID: 20091494
[TBL] [Abstract][Full Text] [Related]
17. Risk analysis by FMEA as an element of analytical validation.
van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Oldenhof MT; Vredenbregt MJ; Barends DM
J Pharm Biomed Anal; 2009 Dec; 50(5):1085-7. PubMed ID: 19640668
[TBL] [Abstract][Full Text] [Related]
18. Preventing blood transfusion failures: FMEA, an effective assessment method.
Najafpour Z; Hasoumi M; Behzadi F; Mohamadi E; Jafary M; Saeedi M
BMC Health Serv Res; 2017 Jun; 17(1):453. PubMed ID: 28666439
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of preanalytical and postanalytical phases in clinical biochemistry laboratory according to IFCC laboratory errors and patient safety specifications.
Zorbozan N; Zorbozan O
Biochem Med (Zagreb); 2022 Oct; 32(3):030701. PubMed ID: 35966260
[TBL] [Abstract][Full Text] [Related]
20. Detecting Preanalytical Errors Using Quality Indicators in a Hematology Laboratory.
Alshaghdali K; Alcantara TY; Rezgui R; Cruz CP; Alshammary MH; Almotairi YA; Alcantara JC
Qual Manag Health Care; 2022 Jul-Sep 01; 31(3):176-183. PubMed ID: 34483302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
